Navigation Links
New drug targets may fight tuberculosis and other bacterial infections in novel way
Date:12/27/2007

NEW YORK (Dec. 27, 2007) -- Over the course of the 20th Century, doctors waged war against infectious bacterial illness with the best new weapon they had: antibiotics.

But the emergence of dangerous, multi-drug resistant strains of tuberculosis and other killer infections means that in the 21st century antibiotics are losing ground against bacterial disease.

Now, researchers from Weill Cornell Medical College in New York City say exciting new molecular targets -- so-called "virulence factors" that bacteria use to thrive once they are in the host -- present an alternative, potent means of stopping TB, leprosy and other bacterial illness.

"We have developed the first inhibitor of a key small molecule from Mycobacterium tuberculosis and Mycobacterium leprae (which causes leprosy) utilized to subvert human host's defenses and damage and invade human host's cells during infection," explains study senior author Dr. Luis Quadri, Associate Professor of Microbiology and Immunology at Weill Cornell.

"With this work, we now have proof of principle for the inhibition of this virulence factor in bacteria cultured in the lab. Our next step is to explore whether this inhibitor can stop these pathogens from multiplying in a mouse host, curtailing infection," Dr. Quadri says.

The findings -- published online today in Chemistry and Biology and appearing in the journal's Jan. 26 print edition -- highlight what Dr. Quadri has called a "paradigm shift" in infectious disease research.

"We are moving beyond antimicrobials such as antibiotics, which kill the bacterium directly, to anti-infectives, that may have no effect against the pathogen in the test tube but which do compromise its ability to infect and spread in the host," he explains. "We believe that the expansion of the drug armamentarium to include such anti-infective drugs could help the fight against multi-drug resistant infection that has become such a challenge tod
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

2

GOOD

Page: 1 2 3

Related biology news :

1. Nicotinic receptors may be important targets for treatment of multiple addictions
2. Central targets may hinder wider waste management objectives
3. UIC researchers find promising new targets for antibiotics
4. New X-ray technique targets terrorists and tumors
5. Clemson chemists discover new way antioxidants fight debilitating diseases
6. Social habits of cells may hold key to fighting diseases
7. Advance in effort to fight malaria by tricking the mosquitos sense of smell
8. Yale scientists use nanotechnology to fight E. coli
9. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
10. Japanese beetle may help fight hemlock-killing insect
11. When it comes fighting to C. difficile, the Palme dOr goes to soap and warm water

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Ecologists have at last worked out a way of using...size of bird populations. This is the first time s...translated into accurate estimates of bird species... in the British Ecological Society,s Journal of A...t could lead to a major advance in our ability to ...
(Date:11/26/2009)... CAMBRIDGE, Mass. (November 26, 2009) Whitehead r...reen for human cells to pinpoint specific genes an...aper in Science . , In most human cell cultures...om the father and one from the mother. Gene inacti...e when one copy is inactivated, the second copy us...
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aureu...nnihilation as low-temperature plasma prototype de...sy and unfailing bactericidal cocktails. , Two p...cient disinfection of healthy skin (e.g. hands and...ia can pose a lethal threat; and another to shoot ...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 1Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 2Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 3Organic weed control for dandelions 9824 1Organic weed control for dandelions 9824 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2
...rmone in African Americans known to potentially ca...he senior author of a study in the September issue... professor of kinesiology at Temple Universitys Co...terone, influences the kidneys regulation of blood...e development of hypertension because it causes th...
...ey say in the summer movies) theres a killer in th...udden, and deadly. Unknowingly, we have all been p...u personally are not in any danger. Its the woods ... accomplice. , Melodrama aside, the threat is ver...oying plant disease known as Sudden Oak Death. Cau...
...ople are biologically more susceptible to drug add...o speculate why. , In the August 15, 2007 issue o...University of Chicago report on a study that may h...t rats most likely to self-administer addictive dr... more responsive than the same receptor in rats le...
Other Biology News:Understanding hypertension in African Americans proves elusive 2Humans fostering forest-destroying disease 2Humans fostering forest-destroying disease 3Humans fostering forest-destroying disease 4Nicotinic receptors may be important targets for treatment of multiple addictions 2
(Date:11/24/2009)...dpointhasbeenmetforpatientswithadvanced-stage,orre.../PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ:...icalcompanyfocusedonendocrinetherapyandoncology,to...thitstargetedcytotoxicpeptideconjugate,AEZS-108(fo...ometrialcancer.Inapersonalizedhealthcareapproach,t...
(Date:11/24/2009)...009/PRNewswire-FirstCall/--ArenaPharmaceuticals,In...cheduledtopresentatthePiperJaffray21stAnnualHealth...me(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNe...tiveOfficer,isscheduledtoprovideanoverviewofthecom...ograms. ,, Aliveaudiowebcastofthepresentationwi...
(Date:11/24/2009)... Program Connects Customers with Partners Validate...A Genotek Products , Otta... a leading provider of products for biological sam...ay announced its new global partner program. The p...otek,s partner community and is designed to help p...
(Date:11/23/2009)...3, 2009 In a provocative new study, a University ...e emissions the major cause of global warming ca...apses or society builds the equivalent of one new ...ely that there will be any substantial near-term d...rbon dioxide emission rates," says the new paper b...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...g to be highlighted, TSX Exchange Symbol: RVX, C...ix Corp.,("Resverlogix" or the "Company") (TSX:RVX...rug is featured prominently in an article titled,"... the current edition of,Expert Opinion of Emerging...e pharmaceutical industry. The article written by ...
...RNewswire-FirstCall/ --,China-Biotics, Inc. (OTC B...y"), a leading Chinese firm specializing in the ma...tribution of probiotics products,today announced i...lobal,Market ("Nasdaq")., "This is an important m...o working with Nasdaq to fulfill all of its listin...
... to see inside a magnet that,s smaller than the he...e invented a new kind of MRI technique to do just ...evelopment of extremely small computers, and even ...n blood vessels that play a role in diseases such ...l Review Letters, the scientists report the first...
Other Biology Technology:Resverlogix's Lead Drug Featured in Key Scientific Publication 2China-Biotics, Inc. Files Application for Nasdaq Listing 2New kind of MRI enables study of magnets for computer memory 2New kind of MRI enables study of magnets for computer memory 3
...g Purification Kits enable rapid analytical to med...teins produced from appropriate vectors. Sufficien...1 mg target protein under native or denaturing con...n Agarose, which specifically retains STag fusion ...
Anti-S-100 protein, ab heterodimer Monoclonal Antibody, Unconjugated from HyTest Ltd.
Baker's yeast (S. cerevisiae) Hexokinase and glucose-6-phosphate dehydrogenase from Sigma-Aldrich
...ents (g/L):,Tryptone, 10 ,Yeast extract, 5 ,...erric ammonium citrate, 0.5 ,IPTG, 0.03 ,-Gal...genic substrate for -galactosidase. The enzymatic ...black insoluble precipitate. Lac+ colonies grown i...
Biology Products: